Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study)

Clinical trial NCT03203473 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT03203473

Sponsor

Toni Choueiri, MD

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2017-10-26

Primary completion

2021-11-30

Enrollment

85

View on ClinicalTrials.gov